| 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 472,9 k € | -15.0% | 556,5 k € | -25.0% | 742,3 k € | +257.0% | 207,9 k € | -51.9% | 432,1 k € | -4.7% | 453,6 k € | -13.2% | 522,5 k € | +10.0% | 475,0 k € | +11.1% | 427,6 k € | +32.7% | 322,2 k € | +52.5% | 211,3 k € | |
| EBITDA | 471,6 k € | -14.9% | 554,2 k € | -25.2% | 741,1 k € | +258.3% | 206,8 k € | -52.0% | 430,9 k € | -4.8% | 452,4 k € | -13.1% | 520,5 k € | +10.0% | 473,2 k € | +11.0% | 426,3 k € | +32.6% | 321,5 k € | +52.7% | 210,6 k € | |
| Operating profit | 468,3 k € | +37.6% | 340,5 k € | -37.3% | 543,3 k € | +999.7% | 49,4 k € | -83.7% | 303,3 k € | -14.6% | 355,2 k € | -20.6% | 447,3 k € | +10.1% | 406,2 k € | +1.9% | 398,5 k € | +32.2% | 301,4 k € | +50.0% | 200,9 k € | |
| Profit/loss | 412,1 k € | +86.7% | 220,8 k € | -42.1% | 381,1 k € | +753.9% | 44,6 k € | -78.8% | 210,4 k € | -10.2% | 234,4 k € | -13.5% | 270,9 k € | +7.2% | 252,7 k € | -2.4% | 258,8 k € | +37.1% | 188,8 k € | +40.3% | 134,6 k € | |
| Equity | 1,5 M € | +9.5% | 1,4 M € | -3.5% | 1,4 M € | +0.5% | 1,4 M € | +11.2% | 1,3 M € | +19.4% | 1,1 M € | +27.6% | 848,2 k € | +46.9% | 577,3 k € | +77.9% | 324,6 k € | -3.3% | 335,7 k € | +128.4% | 147,0 k € | |
| Total assets | 1,6 M € | +8.6% | 1,5 M € | -3.5% | 1,5 M € | +6.5% | 1,4 M € | +8.5% | 1,3 M € | +11.4% | 1,2 M € | +26.5% | 946,2 k € | +10.5% | 856,5 k € | +2.9% | 832,6 k € | +18.4% | 703,0 k € | +52.7% | 460,4 k € | |
| Cash | 53,6 k € | -61.1% | 137,9 k € | -3.5% | 143,0 k € | -8.2% | 155,7 k € | +54.2% | 101,0 k € | -60.8% | 257,8 k € | +13.5% | 227,2 k € | -7.3% | 245,1 k € | +43.9% | 170,3 k € | -42.3% | 295,3 k € | +18.1% | 250,0 k € | |
| Debts | 87,3 k € | -5.6% | 92,5 k € | -4.3% | 96,6 k € | +908.1% | 9,6 k € | -76.2% | 40,2 k € | -64.7% | 114,0 k € | +16.3% | 98,0 k € | -64.9% | 279,2 k € | -45.0% | 508,0 k € | +38.3% | 367,3 k € | +17.2% | 313,4 k € | |
Private limited company · Aalst · incorporated on 14/01/2013
Private limited company profitable and well capitalised. Cash position declining (-61.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. MOTTRIE ALEXANDRE, UROLOOG is a Private limited company incorporated in 2013. Its main activity is: Specialist medical practice activities. Its registered office is in Aalst.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.